Ondine Biomedical (LON:OBI) Trading 1.8% Higher – Still a Buy?

Ondine Biomedical Inc. (LON:OBI) shares traded up 1.8% during mid-day trading on Monday . The company traded as high as C$14.79 and last traded at C$14.50. 96,568 shares changed hands during mid-day trading, a decline of 70% from the average session volume of 318,726 shares. The stock had previously closed at C$14.25.

Ondine Biomedical Stock Performance

The company has a market capitalization of C$7.50 billion, a P/E ratio of -207.14 and a beta of 0.10. The business has a 50-day moving average of C$14.71 and a 200-day moving average of C$11.97. The company has a debt-to-equity ratio of 25.95, a current ratio of 1.36 and a quick ratio of 8.26.

Ondine Biomedical Company Profile

Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens.

Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings.